Our study demonstrates that ethanolic extract of Hypericum alpestre, particularly when combined with the nitric oxide synthase inhibitor L-NAME, significantly modulates the PI3K/Akt signaling pathway and its downstream effectors in human lung adenocarcinoma (A549) and triple-negative breast cancer (MDA-MB-231) cells. This evidence concerns the gene AKT1 and triple-negative breast carcinoma.